Quercetin liposomes via nasal administration reduce anxiety and depression-like behaviors and enhance cognitive performances in rats

American Journal of Pharmacology and Toxicology

Volumn 5, Issue 2, 2010, Pages 80-88

  Tong Un, Terdthai ^a   Wannanon, Panakaporn ^a   Wattanathorn, Jintanaporn ^a   Phachonpai, Wathita ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Anti depression like activity; Anxiety; Cognitive enhancing effect; Nasal administration; Quercetin liposomes

Indexed keywords

LIPOSOME; QUERCETIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ANXIETY; ARTICLE; BLOOD BRAIN BARRIER; COGNITION; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENCY; ENCAPSULATION; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; RAT; SPATIAL MEMORY; TRANQUILIZING ACTIVITY;

RATTUS;

EID: 77953178525     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2010.80.88     Document Type: Article

References (46)

1. Aan Het Rot, M., S.J. Mathew and D.S. Charney, 2009. Neurobiological mechanisms in major depressive disorder. Can. Med. Assoc. J., 180: 305-313.PMID: 19188629
2. Ballenger, J., 1999. Current treatments of the anxiety disorders in adults. Biol. Psychiat., 46: 1579-1594.
3. Bhattaram, V.A., U. Graefe, C. Kohlert, M. Veit and H. Derendorf, 2002. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomed., 9:1-33.
4. Billett, E.E., 2004. Monoamine Oxidase (MAO) in human peripheral tissues. Neurotoxicol., 25: 139-148.PMID: 14697888
5. Boer, V.C.J., A.A. Dihal, H. van derWoude, I.C.W. Arts and S. Wolffram et al., 2005. Tissue distribution of quercetin in rats and pigs. J. Nutr., 135:1617-1618.PMID: 15987855
6. Bonina, F., M. Lanza, L. Montenegro, C. Puglisi and A. Tomaino et al., 1996. Flavonoids as potential agents against photo-oxidative skin damage. Int. J. Pharm., 145: 87-94.
7. Borsini, F. and A. Meli, 1988. Is the forced swimming test a suitable model for revealing antidepressant activity. Psychopharmacol. Berl., 94: 147-160.PMID: 3127840
8. Cassel, J.C. and H. Jeltsch, 1995. Serotonergic modulation of cholinergic function in the central nervous system: Cognitive implications. Neuroscience, 69: 1-41.PMID: 8637608
9. Chimenti, F., F. Cottiglia, L. Bonsignore, L. Casu and M. Casu et al., 2006. Quercetin as the activeprinciple of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: Extraction, biological analysis and computational study. J. Nat. Prod., 69: 945-949.PMID: 16792415
10. Cho, J.Y., I.S. Kim, Y.H. Jang, A.R. Kim and S.R. Lee, 2006. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci. Lett., 404: 330-335.PMID: 16806698
11. Detke, M., M. Rickels and I. Lucki, 1995. Active behaviors in the rat forced swimming test differentially activated by serotonergic and noradrenergic antidepressants. Psychopharmacol., 121: 66-72.PMID: 8539342
12. Dimpfel, W., 2009. Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action. Phytomed, 16: 287-294. PMID: 19303757
13. Edmondson, D.E., A. Mattevi, C. Binda, M. Li, F. Hubalek, 2004. Structure and mechanism of monoamine oxidase. Curr. Med. Chem., 11: 1983-1993.PMID: 15279562
14. Formica, J.V. and W. Regelson, 1995. Review of the biology of quercetin and related bioflavonoids. Food. Chem. Toxicol., 33: 1061-80.PMID: 8847003
15. Golden, T.R., D.A. Hinerfeld, S. Melov, 2002. Oxidative stress and ageing: Beyond correlation. Aging Cell 1: 117-123.PMID: 12882341
16. Goutman, J.D. and D.J. Calvo, 2004. Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABAρ1 receptor. Br. J.Pharmacol., 141: 717-727.PMID: 14732759
17. Guo, J., Q. Ping, G. Jiang, L. Huang and Y. Tong, 2003. Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int. J. Pharm., 260: 167-173
18. Huang, S.L., C.L. Hsu and G.C. Yen, 2006. Growth inhibitory effect of quercetin on SW 872 human liposarcoma cells. Life Sci., 79: 203-209
19. Indian Council of Medical Research, (ICMR), 2001. Developments in mental health scenario: Need to stop exclusion-dare to care. ICMR Bull., 31: 1-9. http://www.emro.who.int/MNH/WHD/WHDBrochure.pdf
20. Illum, L., 2000 Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci., 11: 1-18.PMID: 109137
21. Krauze L., 2006. Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res., 23: 2493-2504.PMID: 16972184 DOI:10.1007/s11095-006-9103-5
22. Kulkarni, S.K. and P.C. Dandiya, 1973. Effects of antidepressant agents on open field behavior in rats. Psychopharmacologia, 33: 333-338.PMID: 4798172
23. Lamson, D.W. and M.S. Brignall, 2000. Antioxidants and cancer. Part III. Quercetin. Altern. Med., 5: 196-208.PMID: 10869101
24. Liang, M.T., N.M. Davies and I. Toth, 2005. Encapsulation of lipopeptides within liposomes: Effect of number of lipid chains, chain length and method of liposome preparation. Int. J. Pharm., 301: 247-254.PMID: 16054787
25. Lister, R.G., 1987. The used of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92: 180-185.PMID: 3110839
26. Lucassen, P.J., E. Fuchs and B. Czeh, 2004. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol. Psychiat., 55: 789-796. PMID: 15050859
27. Manach, C., C. Morand, V. Crespy, C. Demignee and O. Texier et al., 1998. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett., 426: 331-336.PMID: 9600261
28. Mathison, S., R. Nagilla and U.B. Kompella, 1998. Nasal route for direct delivery of solutes to the central nervous system: Factor fiction. J. Drug Target., 5: 415-441.PMID: 9783675
29. McNamara, R.K. and W.S. Ronald, 1993. The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res. Rev. 18: 33-49.PMID: 8467349
30. Middleton, E., C. Kandaswami and T.C. Theoharides, 2000. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharm. Rev., 52: 673-751.PMID: 11121513
31. Myhrer, T., 2003. Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks. Brain Res. Rev., 41: 268-287.PMID: 12663083
32. Ohnishi, E. and H. Bannai, 1993. Quercetin potentiates TNF-induced antiviral activity. Antiv. Res., 22: 327-331.PMID: 8279819
33. Orsetti, M., A. Dellarole, S. Ferri, P. Ghi., 2003.Acquisition, retention and recall of memory after injection of RS67333, a 5-HT (4) receptor agonist, into the nucleus basalis magnocellularis of the rat. Learn. Mem., 10: 420-426.PMID: 14557615
34. Pellow, S., P. Chopin, S.E. File and M. Briley, 1985. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 14: 149-167
35. Porsolt, R.D., G. Anton, N. Blavet and M. Jalfre, 1978. Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47: 379-391.PMID: 204499
36. Riedel, G., B. Platt and J. Micheau, 2003. Glutamate receptor function in learning and memory. Behav. Brain Res., 140: 1-47.PMID: 12644276
37. Rodriguez, R.J., C.L. Miranda, J.F. Stevens, M.L. Deinzer and D.R. Buhler, 2001. Influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food Chem. Toxicol., 39: 437-445.PMID: 11313109
38. Sharma, A., U.S. Sharma, 1997. Liposomes in drug delivery: Process and limitations. Int. J. Pharm., 154:123-140.DOI: 10.1016/S0378-5173(97)00135-X
39. Southwick, S.M., M. Vythilingam, D.S. Charney, 2005. The psychobiology of depression and resilience to stress: Implications for prevention and treatment. Annu. Rev. Clin. Psychol., 1: 255-291.PMID: 17716089
40. Steckler, T. and A. Sahgal, 1995. The role of serotoninergic-cholinergic interactions in the mediation of cognitive behavior. Behav. Brain Res., 67: 165-199.PMID: 7779290
41. Sullivan, G., J. Coplan, J. Kent and J. Gorman, 1999. The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobia. Biol. Psychiat., 46: 1205-1218.PMID: 10560026
42. Wall P.M., C. Messier, 2000. Ethological confirmatory factor analysis of anxiety-like behavior in the murine elevated plus-maze. Behav. Brain. Res., 114: 199-212.PMID: 10996061
43. Wang, X., H. He, W. Leng and X. Tang, 2006. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method. Int. J. Pharm., 317: 40-46.
44. Youdim, K.A., M.Z. Qaiser, D.J. Begley, C.A. Rice Evans and N.J. Abbott, 2004. Flavonoid permeability across an in situ model of the blood-brain barrier. Free. Radic. Biol. Med., 36: 592-604.PMID: 14980703
45. Young S., S. Gauthier, 1981. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acidand indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J. Neurol. Neurosurg. Psychiat., 44: 323-327.PMID: 616580988
46. Zu, Y., C. Li, Y. Fu and C. Zhao, 2006. Simultaneous determination of catechin, rutin, quercetin kaempferol and isorhamnetin in the extract of sea buckthorn (Hippophae rhamnoides L.) leaves by RP-HPLC with DAD. J. Pharm. Biom. Anal., 41: 714-719.PMID: 16520013